Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank83
3Y CAGR+37.0%
5Y CAGR-1.4%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+37.0%/yr
Annual compound
5Y CAGR
-1.4%/yr
Recent acceleration
Percentile
P83
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.72M+48.2%
2024$1.16M-45.5%
2023$2.13M+218.7%
2022$669000.00+90.1%
2021$352000.00-80.9%
2020$1.84M-
2019$0.00+100.0%
2018$-533000.00-312.7%
2017$250607.00-
2016$0.00-